NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 42 min 44 sec ago
Notice of NINR's Participation in PA-18-271 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)
Notice NOT-NR-18-003 from the NIH Guide for Grants and Contracts
Notice of Technical Assistance Webinar for RFA-HL-19-014: Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE)
Notice NOT-HL-18-605 from the NIH Guide for Grants and Contracts
Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PA-18-048 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
Notice NOT-EB-18-007 from the NIH Guide for Grants and Contracts
Notice of NCI's Participation on PA-18-498, End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional)
Notice NOT-CA-18-032 from the NIH Guide for Grants and Contracts
Notice of NCI's participation on PA-18-499, End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional)
Notice NOT-CA-18-033 from the NIH Guide for Grants and Contracts
Notice of NINR's Participation in PA-18-281 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01 Clinical Trial Optional)
Notice NOT-NR-18-004 from the NIH Guide for Grants and Contracts
NINDS Notice to Clarify the Types of Clinical Trial Applications NINDS Will Support Under PA-18-159 "Mechanisms, Models, Measurement, and Management in Pain Research (R21 - Clinical Trial Optional)"
Notice NOT-NS-18-016 from the NIH Guide for Grants and Contracts
Notice of Change to PAR-17-233 "Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)"
Notice NOT-CA-18-055 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Cardiothoracic Surgical Trials Network Renewal (UM1)
Notice NOT-HL-18-606 from the NIH Guide for Grants and Contracts
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-18-005 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications for the Sexually Transmitted Infections Cooperative Research Centers (STI CRC) program. This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum. In addition, the FOA will support the development of prophylactic vaccines for herpes simplex virus (HSV).
Notice NOT-HL-18-607 from the NIH Guide for Grants and Contracts
Notice NOT-PM-18-002 from the NIH Guide for Grants and Contracts
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp)
Funding Opportunity PA-18-713 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) Office of the Director announces the availability of administrative supplements to expand existing research to focus on Sexual and Gender Minority (SGM) health. Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) are notified that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for administrative supplements are considered prior approval requests (as described in Section 184.108.40.206 of the NIH Grants Policy Statement) and will be routed directly to the Grants Management Officer of the parent award. Although requests for administrative supplements may be submitted through this FOA, there is no guarantee that funds are available from the awarding IC or for any specific grant. All applicants are encouraged to discuss potential requests with the awarding IC. Additionally, prior to submission, applicants must review the awarding IC's web site to ensure they meet the IC's requirements. SGM populations include, but are not limited to, lesbian, gay, bisexual, and transgender people, and individuals with differences or disorders of sexual development (sometimes referred to as intersex or as specific diagnoses). This trans-NIH effort, which involves multiple Institutes, Centers and Offices from across NIH, is intended to encourage investigation in this growing, field of research. To increase our collective understanding of the broad range of research needed to address the unique health issues of SGM populations, the supplement will focus on areas of research interest, including, but not limited to: studies on increased disease risk; mental, behavioral and social health; approaches to personalized medicine; access to care; reprod
Informational Webinar for Alzheimer's Disease Related Dementia (ADRD) Funding Opportunity Announcements (FOAs) for PAR-18-661, RFA-NS-18-015, RFA-NS-18-025 and RFA-NS-18-024
Notice NOT-NS-18-050 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-FD-18-015 from the NIH Guide for Grants and Contracts. The FDA Center for Drug Evaluation and Research is encouraging applications for projects to expedite development of data standards and terminologies to support human drug development and evaluation. The primary objective is to support research and the development of non-proprietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics. Projects may focus on solutions to general data standards development and implementation challenges or on specific clinical concepts, domains, or therapeutic areas where standardization is needed.
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-712 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to advance the discovery and characterization of primary immunodeficiency diseases, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.
Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-19-016 from the NIH Guide for Grants and Contracts. This FOA encourages new R43 applications for design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for aging adults. These may be novel sensor or monitoring systems, home-use point-of-care devices, home or mobile therapy or rehabilitation tools, or information systems and should have the goal of fostering healthy and independent living. The development of such technologies should incorporate specific human factors for people with disabilities, people aging with mild impairments, as well as individuals with chronic conditions. Technology usability for these populations must be incorporated into the design early. Usability considerations include but are not limited to patient-facing displays, hearing and visual impairments considerations, tactile limitations, and literacy. These improvements in technology design could yield more accurate and earlier detection of changes that may interfere with healthy and independent living for older adults.
Changes in NIGMS Support of Academic Research Enhancement Award (R15) Grants in the Basic Biomedical Sciences
Notice NOT-GM-18-021 from the NIH Guide for Grants and Contracts
Notice of Correction of Funding Opportunity Number for PAR-18-700/PA-18-700 NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
Notice NOT-DC-18-006 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-18-710 from the NIH Guide for Grants and Contracts. The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. This NINDS K22 is specifically designed to facilitate the transition of NINDS intramural neurologist- and neurosurgeon-scientists to independent, academic faculty positions that support clinician-scientists to engage in independently funded scientific research as well as clinical activities.
NIH Funding Opportunities
- Computational fluid dynamics (CFD) and discrete element modeling (DEM) approach for predictions of dry powder inhaler (DPI) drug delivery
- Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
- International Bioethics Research Training Program (D43 Clinical Trial Optional)
- Three-Dimensional Approach for Modeling Nasal Mucociliary Clearance via Computational Fluid Dynamics (CFD)
- Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems